InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Lian Brian, 董事长兼首席执行官. Insider active across 1 company, notably Viking Therapeutics, Inc.. In total, 25 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €7.2m. History available since 28 September 2021. The latest transaction was disclosed on 28 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lian Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
221,667 股0Common Stock, par value $0.00001 per shareSEC:0001193125-26-324448:0
148,517 股@ US$33.31530.12% mcap43.6% 占其流量Common Stock, par value $0.00001 per shareSEC:0001193125-26-324448:1
78,400 股0Common Stock, par value $0.00001 per shareSEC:0001193125-26-003113:0
70,084 股0Common Stock, par value $0.00001 per shareSEC:0001193125-25-254299:0
48,333 股0Common Stock, par value $0.00001 per shareSEC:0000950170-25-093793:0
92,800 股0Common Stock, par value $0.00001 per shareSEC:0000950170-25-002487:0
166,130 股@ US$7.7720.0% 占其流量Common Stock, par value $0.00001 per shareSEC:0000950170-24-108576:0
1,000 股@ US$7.770.1% 占其流量Common Stock, par value $0.00001 per shareSEC:0000950170-24-099982:0
112,870 股@ US$7.7713.7% 占其流量Common Stock, par value $0.00001 per shareSEC:0000950170-24-098803:0
41,000 股0Common Stock, par value $0.00001 per shareSEC:0000950170-24-088544:0
221,667 股0Common Stock, par value $0.00001 per shareSEC:0001209191-24-005117:0
221,667 股0Common Stock, par value $0.00001 per shareSEC:0001209191-24-004233:0
45,000 股@ US$29.9021.6% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-24-003068:0
49,079 股@ US$1.231.0% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-24-003010:0
85,000 股@ US$1.231.7% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-24-002512:0
35,000 股@ US$1.230.7% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-24-002458:0
150,000 股0Common Stock, par value $0.00001 per shareSEC:0001209191-24-000931:0
45,000 股@ US$22.4515.9% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-23-026356:0
35,000 股@ US$21.4511.9% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-23-025277:0
125,000 股@ US$2.154.3% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-23-024724:0
54,336 股@ US$1.881.6% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-23-024228:0
115,852 股@ US$1.232.3% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-23-022400:0
121,667 股0Common Stock, par value $0.00001 per shareSEC:0001209191-23-001340:0
36,319 股@ US$4.881.6% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-22-001986:0
55,500 股0Common Stock, par value $0.00001 per shareSEC:0001209191-21-058253:0
25 条申报中的 25 条
About Lian Brian
Lian Brian is Président-Directeur Général and is linked to Viking Therapeutics, Inc. (XNAS) as President & CEO. He has 23 filings in total, and across the sampled recent filings the most frequent transaction nature is Attribution, with 0 EUR of buys and 2854927 EUR of sells between 2021-09-30 and 2026-01-05.
